Title : PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia.

Pub. Date : 2013 Apr

PMID : 23160450






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Chronic lymphocytic leukemia (CLL) cells with aggressive clinical properties express lipoprotein lipase (LPL), which generates activating ligands for the nuclear receptor peroxisome proliferator activated receptor (PPAR)alpha and allows fatty acids to be used as fuel. Fatty Acids lipoprotein lipase Homo sapiens
2 Chronic lymphocytic leukemia (CLL) cells with aggressive clinical properties express lipoprotein lipase (LPL), which generates activating ligands for the nuclear receptor peroxisome proliferator activated receptor (PPAR)alpha and allows fatty acids to be used as fuel. Fatty Acids lipoprotein lipase Homo sapiens